In part I agree, we know the quarterly will be out shortly.
SI may also be seeing some data from the work started almost 3 months back. So possible that he thinks it better not to raise a objection to the FDAs rather strange directions.
How can they justify continuing a hold on the clinical program for GVHD when as of just 3 months ago by there statments we had very good reason to think approval was reasonable.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Type A Meeting with FDA
Ann: Mesoblast Type A Meeting with FDA, page-513
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.318B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $4.175M | 3.568M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 79071 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 19216 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 59001 | 1.180 |
12 | 59122 | 1.175 |
13 | 179705 | 1.170 |
15 | 242700 | 1.165 |
10 | 55646 | 1.160 |
Price($) | Vol. | No. |
---|---|---|
1.185 | 61739 | 14 |
1.190 | 196442 | 16 |
1.195 | 111463 | 12 |
1.200 | 154327 | 20 |
1.205 | 87816 | 4 |
Last trade - 15.52pm 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |